CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Fuji Pharma Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Fuji Pharma Co Ltd
5-7, Samban-cho
6F, Seito Kaikan,
Phone: +81 335563344p:+81 335563344 CHIYODA-KU, TKY  102-0075  Japan Ticker: 45544554
Business Summary
Fuji Pharma Co., Ltd. is a Japan-based company mainly engaged in the manufacture and sale of medical products. The Company is engaged in the manufacture and sale of hormone medicines for obstetrics and gynecology department, as well as injectable drugs for radiological department such as radiopaque dye for urinary tracts and blood vessels through its branches. In addition, the Company purchases its main pharmaceutical ingredients from its main parent company.
(Source: F-4)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/20239/30/2023Yes----

Industries
SIC Code Description
2833 Medicinal chemicals and botanical products
2834 Pharmaceutical preparations

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, Representative Director HirofumiImai 59 4/1/2016 12/1/1990
President, Chief Executive Officer, Chief Director of Research Development, Representative Director TakayukiIwai 59 12/19/2019 12/1/2006
Vice President, Toyama Plant Manager, Director ToyoyukiKamide 58 10/1/2021 10/1/2007
11 additional Officers and Directors records available in full report.

Business Names
Business Name
4554
Fuji Pharma Co., Ltd.
Fuji Pharmaceutical Co., Ltd

General Information
Number of Employees: 1,621 (As of 9/30/2023)
Outstanding Shares: 24,312,335 (As of 12/31/2023)
Shareholders: 8,005
Stock Exchange: TYO
Fax Number: +81 335564455


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, April 19, 2024